Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 21 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
NCT07082868
- Conditions
- Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma (PCNSL), +4 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
NCT04792489
- Conditions
- Central Nervous System Lymphoma, Central Nervous System Neoplasms, Hemic and Lymphatic Diseases, +22 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Phoenix, Arizona, United States
- UC San Diego Health La Jolla, California, United States
NCT06607549
- Conditions
- Central Nervous System Lymphoma
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Jefferson Philadelphia, Pennsylvania, United States
- Brown University Health Rhode Island Hospital Providence, Rhode Island, United States
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
NCT05625594
- Conditions
- Central Nervous System Lymphoma
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT05011045
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Central Nervous System Lymphoma, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04186520
- Conditions
- Central Nervous System Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +28 more
- Locations
-
- Medical College of Wisconsin and Froedtert Hospital Milwaukee, Wisconsin, United States
NCT03375619
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +41 more
- Locations
-
- Froedtert Hospital & Medical College of Wisconsin Milwaukee, Wisconsin, United States
Not Yet Recruiting
Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas
NCT07608731
- Conditions
- Central Nervous System Lymphoma, Large B-cell Lymphoma
- Locations
-
- Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT06031194
- Conditions
- Central Nervous System Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT03342586
- Conditions
- Central Nervous System Lymphoma
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
NCT00103038
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +15 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Completed
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
NCT02652715
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, +76 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01722305
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Burkitt Lymphoma, Central Nervous System Lymphoma, +23 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00916630
- Conditions
- Central Nervous System Lymphoma, Disease Attributes, Pathologic Processes, +2 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT00221325
- Conditions
- Central Nervous System Lymphoma, Eye Neoplasms, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00581737
- Conditions
- Central Nervous System Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Active, Not Recruiting
Acalabrutinib in CNSL
NCT04906902
- Conditions
- Central Nervous System Lymphoma, Recurrent Central Nervous System Lymphoma, Refractory Central Nervous System Lymphoma
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Active, Not Recruiting
A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas
NCT04548648
- Conditions
- Central Nervous System Lymphoma
- Locations
-
- Moffit Cancer Center Tampa, Florida, United States
- Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
- Wake Forest University,The Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
Active, Not Recruiting
Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)
NCT03964090
- Conditions
- Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
NCT03684980
- Conditions
- Central Nervous System Lymphoma
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Dana Farber Cancer Institute (Data Collection and Specimen Analysis) Boston, Massachusetts, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States